Replikins Logo
The biochemistry of rapid replication

home
right
right
right
right
right
right
right
home

  Videos

International H1N1 "Swine Flu" Conference

International H1N1 Swine Flu Conference
Part 1 - C-SPAN Video

The International Swine Flu Conference addressed best practices to prepare for, respond to, and survive a pandemic. Participants focused on the expected infection rates for the coming flu season and efforts to produce and distribute a vaccine.

Synthetic flu vaccine option?

Synthetic flu vaccine option?

Possibility to create a H1N1 synthetic flu vaccine
CNN's Dr. Sanjay Gupta reports.

ABC Boston discusses Bogoch Replikins ABC Boston discusses Bogoch Replikins

ABC Boston discusses Replikins synthetic peptide H1N1 vaccine, produced in 7 days, is available now for testing worldwide. Replikins developed the vaccine based on the same peptide technology which provided the surprise advance warning one year ago that the current H1N1 outbreak/pandemic was on its way



Recent Press

Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased

Boston, November 27, 2009 - Biotech firm Replikins Ltd., which has analyzed the H1N1 virus' genomic data from the 1918 pandemic through the prediction, outbreak, and progress of the current H1N1 pandemic, today issued its latest biochemical analysis of the virus...
Read more Read article

 
New Non-Biological Synthetic Replikins™ Vaccines Shown to Be Effective and Fast; WorldVaccines™, Ltd. Formed for Testing and Distribution Old Biological Vaccines for Emergent Diseases - Too Little, Too Late

Boston, October 19, 2009 - There is increasing evidence that, with best intent, current biological technology cannot supply the world's six billion humans, and animal populations, with vaccines against emerging diseases at a rate that can contend with a disease's rapid appearance and change...
Read more Read article